Lv52
1530 积分 2023-06-20 加入
[Prostatitis syndromes and sporting activities]
6小时前
求助中
Combination locoregional and systemic therapies in hepatocellular carcinoma
1天前
已完结
MET amplification increases the metastatic spread of EGFR-mutated NSCLC
5天前
已完结
Current and Future Approaches in the Management of Non–Small-Cell Lung Cancer Patients With Resistance to EGFR TKIs
5天前
已完结
Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer?
20天前
已完结
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
1个月前
已完结
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study
1个月前
已完结
Treatments for psoriasis: A journey from classical to advanced therapies. How far have we reached?
1个月前
已完结
Psoriasis
1个月前
已完结
皖公网安备34019202002308
